Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer

Gynecologic Oncology

Volumn 136, Issue 3, 2015, Pages 498-504

  Kim, Choon Young ^a   Jeong, Shin Young ^a   Chong, Gun Oh ^a   Son, Seung Hyun ^a   Jung, Ji Hoon ^a   Kim, Do Hoon ^a   Lee, Sang Woo ^a   Ahn, Byeong Cheol ^a   Lee, Jaetae ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

F 18 FDG PET CT; Prognosis prediction; Relapsed epithelial ovarian cancer; Whole body metabolic tumor volume; Whole body total lesion glycolysis

Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; CISPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE F 18; GEMCITABINE; GLUCOSE; PACLITAXEL; TOPOTECAN; RADIOPHARMACEUTICAL AGENT; TUMOR MARKER;

ADULT; AGED; ARTICLE; ASCITES; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CYTOREDUCTIVE SURGERY; DISTANT METASTASIS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; METABOLIC PARAMETERS; OVARY CARCINOMA; PET-CT SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOFREQUENCY ABLATION; SPLEEN METASTASIS; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; EVALUATION STUDY; METABOLISM; MIDDLE AGED; MORTALITY; MULTIMODAL IMAGING; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GLYCOLYSIS; HUMANS; MIDDLE AGED; MULTIMODAL IMAGING; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; ROC CURVE; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84924262217     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.12.032     Document Type: Article

References (20)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. T. Thigpen A rational approach to the management of recurrent or persistent ovarian carcinoma Clin Obstet Gynecol 55 2012 114 130
3. C.K. Lee, R.J. Simes, C. Brown, S. Lord, U. Wagner, and M. Plante Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer Br J Cancer 105 2011 1144 1150
4. M. Petrillo, A. Fagotti, G. Ferrandina, F. Fanfani, B. Costantini, and G. Vizzielli Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors Gynecol Oncol 131 2013 36 41
5. M. Petrillo, L. Pedone Anchora, L. Tortorella, F. Fanfani, V. Gallotta, and M. Pacciani Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: a retrospective analysis Gynecol Oncol 134 2014 257 261
6. C.K. Lee, S. Lord, T. Grunewald, V. Gebski, A.C. Hardy-Bessard, and J. Sehouli Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial Gynecol Oncol 136 2015 18 24
7. H.H. Chung, H.W. Kwon, K.W. Kang, N.H. Park, Y.S. Song, and J.K. Chung Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer Ann Surg Oncol 19 2012 1966 1972
8. 18F-FDG PET/CT in the prognosis of epithelial ovarian cancer Eur J Nucl Med Mol Imaging 41 2014 1898 1906
9. Y. Ebina, H. Watari, M. Kaneuchi, M. Takeda, M. Hosaka, and M. Kudo Impact of FDG PET in optimizing patient selection for cytoreductive surgery in recurrent ovarian cancer Eur J Nucl Med Mol Imaging 41 2014 446 451
10. A.P. Heintz, F. Odicino, P. Maisonneuve, M.A. Quinn, J.L. Benedet, and W.T. Creasman Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer Int J Gynaecol Obstet 95 Suppl. 1 2006 S161 S192
11. E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, and R. Ford New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
12. G.J. Rustin, I. Vergote, E. Eisenhauer, E. Pujade-Lauraine, M. Quinn, and T. Thigpen Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG) Int J Gynecol Cancer 21 2011 419 423
13. R.L. Wahl, H. Jacene, Y. Kasamon, and M.A. Lodge From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors J Nucl Med 50 Suppl. 1 2009 122S 150S
14. 18F-FDG PET/CT associated with serum CA19-9 predicts pancreatic cancer outcome after resection Eur J Nucl Med Mol Imaging 41 2014 1093 1102
15. 18F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma Eur J Nucl Med Mol Imaging 40 2013 1321 1329
16. 18F-FDG PET/CT in post-surgical patients with epithelial ovarian cancer Clin Nucl Med 38 2013 715 720
17. T. Al Rawahi, A.D. Lopes, R.E. Bristow, A. Bryant, A. Elattar, and S. Chattopadhyay Surgical cytoreduction for recurrent epithelial ovarian cancer Cochrane Database Syst Rev 2 2013 CD008765
18. R.Y. Zang, P. Harter, D.S. Chi, J. Sehouli, R. Jiang, and C.G. Trope Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort Br J Cancer 105 2011 890 896
19. 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer Eur J Nucl Med Mol Imaging 39 2012 925 935
20. S.H. Moon, S.H. Hyun, and J.Y. Choi Prognostic significance of volume-based PET parameters in cancer patients Korean J Radiol 14 2013 1 12